Abstract:
Therapeutic members and strands for use in brachytherapy are designed to reduce the tendency for the members and strands (and thus the radioactive sources, thermal ablation implants and/or radiopaque makers, etc. therein) to migrate and/or rotate within a patient's body. In one embodiment a member includes a radioactive source and a material that encapsulates the radioactive source. Such encapsulating material, which is preferably, but not necessarily, bioabsorbable, is likely polymeric or some other plastic material. An outer surface of the encapsulating material includes at least one protrusion, and preferably a plurality of protrusions, to reduce the tendency of the member to migrate and rotate within a patient's body after implantation. Other embodiments are also provided.
Abstract:
Therapeutic members and strands for use in brachytherapy are designed to reduce the tendency for the members and strands (and thus the radioactive sources, thermal ablation implants and/or radiopaque makers, etc. therein) to migrate and/or rotate within a patient's body. In one embodiment a member includes a radioactive source and a material that encapsulates the radioactive source. Such encapsulating material, which is preferably, but not necessarily, bioabsorbable, is likely polymeric or some other plastic material. An outer surface of the encapsulating material includes at least one protrusion, and preferably a plurality of protrusions, to reduce the tendency of the member to migrate and rotate within a patient's body after implantation. Other embodiments are also provided.
Abstract:
A hydraulic refrigeration system (10) employs as a preferred embodiment a hydrocarbon fluid as a refrigerant in combination with a non-miscible carrier fluid. A plurality of stages (110, 210, 310) of hydraulic refrigeration system (10) may be used by conveying the segregated refrigerant vapor from each stage to the entrainer (240, 340) of the next succeeding stage (210, 310). The liquid refrigerant of the last stage (310) is conveyed to an evaporator (416), which may be remotely located. The outflow of the evaporator (416) is conveyed to the entrainer (140) of the first stage (110). Second and succeeding stages include a non-miscible carrier fluid return line (268) connected to the respective separators (214, 314) for returning the non-miscible carrier fluid to the separator (114) of the first stage (110).
Abstract:
A therapeutic member for use in brachytherapy deliverable to an implant site by way of a needle comprises a single radioactive source encapsulated by a bio-absorbable material having an outer surface including one or more ribs encircling the single radioactive source, a leading edge endcap rib and a trailing edge endcap rib. The one or more ribs reduces a tendency of the member to migrate and rotate within a patient's body after implantation. The encapsulating material further includes a first rail formed from the bio-absorbable material extending at least from opposite sides of the outer surface of the encapsulating material along the longitudinal axis of the therapeutic member, and a second rail formed from the bio-absorbable material extending at least from opposite sides of the outer surface of the encapsulating material along the longitudinal axis of the therapeutic member, the second rail arranged in a plane substantially perpendicular to a plane in which the first rail is arranged.
Abstract:
A therapeutic member for use in brachytherapy deliverable to an implant site by way of a needle comprises a single radioactive source encapsulated by a bio-absorbable material having an outer surface including one or more ribs encircling the single radioactive source, a leading edge endcap rib and a trailing edge endcap rib. The one or more ribs reduces a tendency of the member to migrate and rotate within a patient's body after implantation. The encapsulating material further includes a first rail formed from the bio-absorbable material extending at least from opposite sides of the outer surface of the encapsulating material along the longitudinal axis of the therapeutic member, and a second rail formed from the bio-absorbable material extending at least from opposite sides of the outer surface of the encapsulating material along the longitudinal axis of the therapeutic member, the second rail arranged in a plane substantially perpendicular to a plane in which the first rail is arranged.